Literature DB >> 23433134

Association between urinary diversion and quality of life after radical cystectomy.

Michael Metcalfe1, Eric Estey, Niels-Erik Jacobsen, Don Voaklander, Adrian S Fairey.   

Abstract

INTRODUCTION: We examined the association between type of urinary diversion and quality of life (QoL) in patients who underwent radical cystectomy for primary bladder cancer using a validated, disease-specific instrument.
MATERIALS AND METHODS: A cohort of 314 consecutive patients treated with radical cystectomy and urinary diversion for primary bladder cancer between January 2000 and December 2006 was analyzed. Participants were mailed the validated Functional Assessment of Cancer Therapy-Vanderbilt Cystectomy Index (FACT-VCI) questionnaire. Univariable and multivariable linear regression analyses were used to examine the association between type of urinary diversion (ileal conduit versus orthotopic neobladder) and QoL.
RESULTS: Eighty-four out of 168 (50% response rate) evaluable patients completed the FACT-VCI questionnaire. The median follow up duration was 5.6 years (range, 2.1 to 9.3 years). ANOVA showed statistically significant differences favoring orthotopic neobladder urinary diversion with more favorable QoL scores on the FACT-VCI (mean difference 5.6 points, p = .03) and radical cystectomy-specific domain (mean difference 2.9 points, p = .05). However, multivariable linear regression analyses showed no statistically significant association between the type of urinary diversion and QoL (FACT-VCI: β = 4.1 points, p = .177; radical cystectomy-specific: β = 1.5 points, p = .390).
CONCLUSIONS: Type of urinary diversion was not associated with QoL after radical cystectomy. Randomized controlled trials comparing types of urinary diversion using validated, disease-specific QoL instruments are needed.

Entities:  

Mesh:

Year:  2013        PMID: 23433134

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  6 in total

1.  Assessment of the quality of life and sexual functions of patients followed-up for non-muscle invasive bladder cancer: preliminary results of the prospective-descriptive study.

Authors:  Deniz Bolat; Serdar Çelik; Mehmet Erhan Aydın; Özgü Aydoğdu; Bülent Günlüsoy; Tansu Değirmenci; Çetin Dinçel
Journal:  Turk J Urol       Date:  2017-09-12

2.  Comparison of health-related quality of life (HRQoL) between ileal conduit diversion and orthotopic neobladder based on validated questionnaires: a systematic review and meta-analysis.

Authors:  Hangchuan Shi; Han Yu; Joaquim Bellmunt; Jeffrey J Leow; Xuanyu Chen; Changcheng Guo; Hongmei Yang; Xiaoping Zhang
Journal:  Qual Life Res       Date:  2018-06-20       Impact factor: 4.147

Review 3.  Is Health-Related Quality of Life after Radical Cystectomy Using Validated Questionnaires Really Better in Patients with Ileal Orthotopic Neobladder Compared to Ileal Conduit: A Meta-Analysis of Retrospective Comparative Studies.

Authors:  Maria A Cerruto; Carolina D'Elia; Salvatore Siracusano; Antonio B Porcaro; Giovanni Cacciamani; Davide De Marchi; Mauro Niero; Cristina Lonardi; Massimo Iafrate; Pierfrancesco Bassi; Emanuele Belgrano; Ciro Imbimbo; Marco Racioppi; Renato Talamini; Stefano Ciciliato; Laura Toffoli; Michele Rizzo; Francesco Visalli; Paolo Verze; Walter Artibani
Journal:  Curr Urol       Date:  2017-05-30

Review 4.  Radical Cystectomy in Female Patients - Improving Outcomes.

Authors:  Nikolaos Kalampokis; Nikolaos Grivas; Markus Ölschläger; Fahmy Nabil Hassan; Georgios Gakis
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 3.092

5.  Clinical evaluation of patients treated with a detubularised isolated ureterosigmoidostomy diversion after radical cystectomy.

Authors:  Mohammed A Atta; Tamer M Abou Youssif; Ahmed F Kotb
Journal:  Arab J Urol       Date:  2014-06-03

Review 6.  Health Related Quality of life in bladder cancer. Current approach and future perspectives.

Authors:  Anamaria Truta; Tudor Adrian Hodor Popon; George Saraci; Liviu Ghervan; Ioan Victor Pop
Journal:  Clujul Med       Date:  2017-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.